Abstract
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 10488 controls. We identify a genome-wide significant risk locus for AML at 11q13.2 (rs4930561; P = 2.15 × 10-8; KMT5B). We also identify a genome-wide significant risk locus for the cytogenetically normal AML sub-group (N = 1287) at 6p21.32 (rs3916765; P = 1.51 × 10-10; HLA). Our results inform on AML etiology and identify putative functional genes operating in histone methylation (KMT5B) and immune function (HLA).
| Original language | English |
|---|---|
| Article number | 6233 |
| Pages (from-to) | 6233 |
| Journal | Nature communications |
| Volume | 12 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 29 Oct 2021 |
Keywords
- Aldehyde Reductase/genetics
- Case-Control Studies
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Genotype
- HLA Antigens/genetics
- Humans
- Leukemia, Myeloid, Acute/genetics
- Middle Aged
- Polymorphism, Single Nucleotide
- Reproducibility of Results
- Whites/genetics
Fingerprint
Dive into the research topics of 'Genome-wide association study identifies susceptibility loci for acute myeloid leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver